Pricing Log in Create free account

Hemab Therapeutics Holdings, Inc. (COAG) vs Vera Therapeutics, Inc. (VERA)

Hemab Therapeutics Holdings, Inc. and Vera Therapeutics, Inc. are both Biotechnology companies. Hemab Therapeutics Holdings, Inc. and Vera Therapeutics, Inc. are of similar size ($2.2B and $2.1B). Across the 7 metrics below, Hemab Therapeutics Holdings, Inc. leads on 6 and Vera Therapeutics, Inc. on 1.

Valuation

Metric COAG VERA Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 3.22 5.31 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (110.83%) (19.46%) (32.88%)
Free cash flow yield (4.97%) (15.66%) (23.13%)

Profitability

Metric COAG VERA Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (91.75%) (51.96%)
Return on assets (31.79%) (72.32%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric COAG VERA Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) — (69.45%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric COAG VERA Biotechnology median
Debt to equity 0.00 0.18 0.00
Current ratio 35.85 10.92 4.97
Net debt to EBITDA — 2.00 1.01

Dividend

Metric COAG VERA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric COAG VERA Biotechnology median
Market cap 2.13b 2.17b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack